六甲基黄抑制了HeLa细胞中的糖溶性能量代谢
1Department of Obstetrics and Gynecology, Shaanxi Provincial People's Hospital, 256 Youyi West Road, Xi'an City, Shaanxi Province, 710000, China.
BMC cancer
|April 17, 2025
概括
发现6 - 甲基黄可以抑制糖解,这是癌细胞中关键的能量通路. 这种化合物在宫癌中显示出潜在的临床相关性,影响预后和瘤免疫微环境.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 癌细胞表现出高水平的葡萄糖分解,这是癌症治疗中准的代谢脆弱性.
- 六甲基在癌细胞糖解中的作用在很大程度上仍未被探索.
- 了解6-甲基对糖解的影响对于开发新型癌症治疗至关重要.
研究的目的:
- 为了研究6 - 甲基黄对子宫癌细胞中的糖性代谢的影响.
- 探索6 - 甲基黄在宫癌患者的潜在临床相关性.
主要方法:
- 蛋白质组 (TMT,PRM) 和代谢组分析确定了与糖解相关的蛋白质和代谢物的变化.
- 基因和蛋白质结构分析评估了6 - 甲基黄对糖解相关分子的影响.
- 分子对接和相互作用研究确定了6 - 甲基黄与标蛋白的结合亲和力.
- 临床和免疫学相关性分析检查了与患者数据的关系.
- 糖解应激试验和酶测定验证了功能效应.
主要成果:
- 六甲基黄降低了HeLa细胞中与糖分解相关的蛋白质和代谢物的调节.
- 该化合物表现出对九种糖解蛋白的亲和力,具有非共价相互作用.
- 临床分析揭示了6-甲基和子宫癌特征,预后和免疫指标之间的关联.
- 六甲基黄降低了基底糖解,最大的糖解容量和糖解储备,抑制了pyruvate kinase的活性.
结论:
- 六甲基黄通过糖解路径有效抑制癌细胞的能量代谢.
- 该化合物显示出与宫癌的临床特征,预后和免疫微环境的潜在联系.
- 这些发现表明6-甲基黄作为宫癌的潜在治疗剂,需要进一步调查.
相关概念视频
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:24Other Glycolytic Pathways
The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...